Home > Insider Trading > Filing (0001415889-25-003338)

Filing Details

Accession Number:: 0001415889-25-003338
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-02-07 16:00:23
Reporting Period:: 2025-02-06

Filing Date:: 2025-02-07
Accepted Time:: 2025-02-07 16:00:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
59478	Eli Lilly & Co	LLY	Pharmaceutical Preparations (2834)	350470950

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
316011	Lilly Endowment Inc	2801 North Meridian Street Indianapolis IN 46208-0068		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2025-02-06	5,070	$866.07	96,886,908	No	4	S	Direct
Common Stock	Disposition	2025-02-06	6,763	$867.19	96,880,145	No	4	S	Direct
Common Stock	Disposition	2025-02-06	5,736	$868.20	96,874,409	No	4	S	Direct
Common Stock	Disposition	2025-02-06	23,371	$869.23	96,851,038	No	4	S	Direct
Common Stock	Disposition	2025-02-06	28,727	$870.39	96,822,311	No	4	S	Direct
Common Stock	Disposition	2025-02-06	18,918	$871.32	96,803,393	No	4	S	Direct
Common Stock	Disposition	2025-02-06	12,156	$872.24	96,791,237	No	4	S	Direct
Common Stock	Disposition	2025-02-06	15,637	$873.42	96,775,600	No	4	S	Direct
Common Stock	Disposition	2025-02-06	15,032	$874.35	96,760,568	No	4	S	Direct
Common Stock	Disposition	2025-02-06	9,301	$875.21	96,751,267	No	4	S	Direct
Common Stock	Disposition	2025-02-06	8,900	$876.49	96,742,367	No	4	S	Direct
Common Stock	Disposition	2025-02-06	9,278	$877.48	96,733,089	No	4	S	Direct
Common Stock	Disposition	2025-02-06	6,228	$878.36	96,726,861	No	4	S	Direct
Common Stock	Disposition	2025-02-06	12,408	$879.54	96,714,453	No	4	S	Direct
Common Stock	Disposition	2025-02-06	12,726	$880.46	96,701,727	No	4	S	Direct
Common Stock	Disposition	2025-02-06	4,151	$881.37	96,697,576	No	4	S	Direct
Common Stock	Disposition	2025-02-06	2,239	$882.44	96,695,337	No	4	S	Direct
Common Stock	Disposition	2025-02-06	4,855	$883.54	96,690,482	No	4	S	Direct
Common Stock	Disposition	2025-02-06	3,205	$884.56	96,687,277	No	4	S	Direct
Common Stock	Disposition	2025-02-06	2,700	$885.71	96,684,577	No	4	S	Direct
Common Stock	Disposition	2025-02-06	2,325	$886.66	96,682,252	No	4	S	Direct
Common Stock	Disposition	2025-02-06	274	$887.32	96,681,978	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $865.605 to $866.50, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18), (19), (20), (21), and (22) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $866.72 to $867.67, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $867.74 to $868.645, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $868.82 to $869.76, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $869.84 to $870.83, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $870.845 to $871.84, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $871.85 to $872.84, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $872.91 to $873.895, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $873.92 to $874.835, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $874.925 to $875.87, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $875.93 to $876.925, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $876.93 to $877.84, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $877.93 to $878.925, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $878.945 to $879.94, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $880.00 to $880.96, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $881.00 to $881.73, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $882.04 to $882.96, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $883.075 to $883.99, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $884.095 to $885.00, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $885.175 to $886.15, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $886.20 to $887.18, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $887.25 to $887.34, inclusive.